CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 186 filers reported holding CORCEPT THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is 0.52 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $158,987 | +160.6% | 7,828 | +183.2% | 0.00% | – |
Q2 2021 | $61,000 | -30.7% | 2,764 | -62.8% | 0.00% | -100.0% |
Q1 2020 | $88,000 | -70.0% | 7,437 | -64.1% | 0.00% | -50.0% |
Q3 2019 | $293,000 | -40.4% | 20,701 | -50.6% | 0.00% | -60.0% |
Q1 2019 | $492,000 | +53.8% | 41,937 | +115.8% | 0.01% | +66.7% |
Q1 2018 | $320,000 | +290.2% | 19,429 | +180.5% | 0.00% | +200.0% |
Q2 2017 | $82,000 | +95.2% | 6,926 | -10.0% | 0.00% | – |
Q2 2016 | $42,000 | -27.6% | 7,699 | -37.4% | 0.00% | -100.0% |
Q1 2016 | $58,000 | +87.1% | 12,304 | +95.2% | 0.00% | – |
Q4 2015 | $31,000 | +3000.0% | 6,304 | +1776.2% | 0.00% | – |
Q3 2015 | $1,000 | -97.5% | 336 | -94.9% | 0.00% | -100.0% |
Q2 2015 | $40,000 | +73.9% | 6,636 | +61.9% | 0.00% | – |
Q1 2015 | $23,000 | +1050.0% | 4,100 | +485.7% | 0.00% | – |
Q4 2014 | $2,000 | -88.9% | 700 | -89.4% | 0.00% | – |
Q3 2014 | $18,000 | -72.3% | 6,593 | -71.5% | 0.00% | -100.0% |
Q2 2014 | $65,000 | -66.7% | 23,109 | -48.2% | 0.00% | -66.7% |
Q1 2014 | $195,000 | – | 44,638 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
INGALLS & SNYDER LLC | 8,340,193 | $227,229 | 10.94% |
Novo Holdings A/S | 3,377,768 | $92,044,178 | 6.80% |
Parallel Advisors, LLC | 3,723,483 | $101,446,294 | 3.38% |
TANAKA CAPITAL MANAGEMENT INC | 37,569 | $1,024 | 2.92% |
S&T BANK/PA | 334,252 | $9,107 | 1.76% |
Birchview Capital, LP | 50,000 | $1,362,250 | 1.16% |
Granite Investment Partners, LLC | 798,552 | $21,756,549 | 0.91% |
FAS Wealth Partners, Inc. | 310,764 | $8,466,766 | 0.90% |
Clearview Wealth Advisors LLC | 25,258 | $688,155 | 0.85% |
Bridge City Capital, LLC | 43,485 | $1,184,749 | 0.60% |